Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry R Davis

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
JAMA|October 17, 2023
Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-AnalysisStephen P Juraschek, Jiun-Ruey Hu, Jennifer L Cluett, et al.
Archives of Internal Medicine|January 30, 2008
Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Jackson T Wright, Sonja Harris-Haywood, Sara Pressel, et al.
Hypertension (Dallas, Tex. : 1979)|July 26, 2006
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trialFrans H H Leenen, Chuke E Nwachuku, Henry R Black, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 13, 2012
Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialWilliam C Cushman, Barry R Davis, Sara L Pressel, et al.
JACC. Heart Failure|November 19, 2025
Phase I Randomized Study of Cardiac Stem Cells in Patients With Hypoplastic Left Heart Syndrome: The CHILD TrialSunjay Kaushal, Joshua M Hare, William T Mahle, et al.
European Heart Journal|March 25, 2015
The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trialsDavid Preiss, Ross T Campbell, Heather M Murray, et al.
Lancet (London, England)|February 20, 2010
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trialsNaveed Sattar, David Preiss, Heather M Murray, et al.
Hypertension (Dallas, Tex. : 1979)|September 14, 2016
Research Needs to Improve Hypertension Treatment and Control in African AmericansPaul K Whelton, Paula T Einhorn, Paul Muntner, et al.
JACC. Cardiooncology|January 6, 2021
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA TrialRoberto Bolli, Emerson C Perin, James T Willerson, et al.
European Journal of Heart Failure|April 3, 2021
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trialRoberto Bolli, Raul D Mitrani, Joshua M Hare, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
JAMA|October 17, 2023
Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-AnalysisStephen P Juraschek, Jiun-Ruey Hu, Jennifer L Cluett, et al.
Archives of Internal Medicine|January 30, 2008
Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Jackson T Wright, Sonja Harris-Haywood, Sara Pressel, et al.
Hypertension (Dallas, Tex. : 1979)|July 26, 2006
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trialFrans H H Leenen, Chuke E Nwachuku, Henry R Black, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 13, 2012
Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialWilliam C Cushman, Barry R Davis, Sara L Pressel, et al.
JACC. Heart Failure|November 19, 2025
Phase I Randomized Study of Cardiac Stem Cells in Patients With Hypoplastic Left Heart Syndrome: The CHILD TrialSunjay Kaushal, Joshua M Hare, William T Mahle, et al.
European Heart Journal|March 25, 2015
The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trialsDavid Preiss, Ross T Campbell, Heather M Murray, et al.
Lancet (London, England)|February 20, 2010
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trialsNaveed Sattar, David Preiss, Heather M Murray, et al.
Hypertension (Dallas, Tex. : 1979)|September 14, 2016
Research Needs to Improve Hypertension Treatment and Control in African AmericansPaul K Whelton, Paula T Einhorn, Paul Muntner, et al.
JACC. Cardiooncology|January 6, 2021
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA TrialRoberto Bolli, Emerson C Perin, James T Willerson, et al.
European Journal of Heart Failure|April 3, 2021
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trialRoberto Bolli, Raul D Mitrani, Joshua M Hare, et al.
Pageof 19